NovaBay Pharmaceuticals (NBY) Financials

$1.21

$-0.06 (-4.72%)

As on 04-Jun-2026 09:30EDT

Market cap

$52 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	2.46	--	9.78	10.46	14.40	10.20
Cost of Revenue	0.04	0.14	3.30	4.37	6.62	3.69
Gross Profit	-0.04	-0.14	6.48	6.08	7.78	6.52
Operating Expenses	7.82	7.45	12.32	10.19	22.20	15.38
Operating Profit (EBIT)	-4.68	-7.59	-5.84	-4.10	-14.42	-8.86
Other Income	--	--	--	--	--	--
Profit before Tax	525.97	-33.22	-7.21	-6.15	-10.61	-5.82
Provision for Tax	3.45	--	--	0.04	-3.81	-4.62
Profit after Tax (Net Income)	522.59	-22.14	-7.22	-9.64	-10.61	-5.82
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-1.29	--	-8.61	-16.70	-16.27	-6.56

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	138.83	-22.83	-0.13	3.31	10.55	10.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	37.34	30.72	0.71	1.44	1.59	10.37
Current Liabilities	3.58	1.14	2.84	4.28	4.26	3.44
Total Liabilities	183.32	9.04	3.42	9.03	16.40	23.98

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	160.69	0.36	1.49	1.88	5.07	10.81
Current Assets	19.05	8.68	1.94	7.15	11.33	13.17
Total Assets	183.32	9.04	3.42	9.03	16.40	23.98
Total Debt*	0.64	0.78	1.67	2.74	2.04	0.55
Net Current Assets	15.48	7.53	-0.91	2.88	7.08	9.73

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-8.43	-5.18	-4.26	-6.65	-9.19
Cash Flow from Investing Activities	--	--	1.06	-0.02	-0.11	-12.05
Cash from Financing Activities	--	4.62	1.50	1.91	4.63	16.79
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	16.55	-3.80	-1.48	-9.78	-5.60	-31.50
Cash EPS ($)	--	-3.78	-1.40	-9.50	-5.35	-30.85
Adjusted Book Value ($)	--	--	--	3.36	5.58	55.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.45	-1.06	-4.32	-3.52	-49.71
Free Cash Flow per Share ($)	--	-1.45	-1.06	-4.34	-3.57	-49.99

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	215.94	-190.15	-103.38	-90.99	-49.48
ROE (%)	744.12	192.91	-453.56	-139.03	-102.37	-51.79
ROA (%)	532.56	-355.45	-115.97	-75.81	-52.54	-29.70
EBIT Margin (%)	-188.51	--	-64.47	-42.57	-53.32	-86.85
Net Margin (%)	21,217.70	--	-73.85	-92.20	-73.65	-57.08
Cash Profit Margin (%)	0.25	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-73.96	-1.00	-0.06	-0.27	0.41	0.03
EBIT Growth (%)	18.39	-20.28	-41.68	42.04	13.34	-37.91
Net Profit Growth (%)	14,174.57	-206.53	25.07	9.13	-82.14	47.24
EPS Growth (%)	5,534.46	-1.57	0.85	-0.75	0.82	0.51
Book Value Growth (%)	2,242.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.48	-0.41	-0.02	-0.35	-0.01
Price / Book Value	0.24	-1.44	-22.76	0.06	0.35	0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.34	-3.44	-0.71	0.05	-0.05	0.79
Close Price ($)	1.49	28.20	3.01	35.00	341.25	2,306.68
High Price ($)	99.75	32.50	45.40	465.50	2,619.66	10,963.75
Low Price ($)	1.11	2.30	1.81	35.00	217.00	2,235.63
Market Cap ($ Cr)	51.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.03	-12.96	0.83	0.19	0.05
Short term debt to equity ratio	0.00	-0.02	-7.47	0.49	0.04	0.03
Current Ratio	5.33	7.60	0.68	1.67	2.66	3.83
Quick Ratio	5.33	--	0.41	1.00	1.85	2.89
Interest Coverage	4,655.56	-27.38	-6.98	-2.63	-2.02	-2.92

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	3.98	7.26	14.00	16.52
Asset Turnover	0.03	--	1.57	0.82	0.71	0.52
Receivable days	--	--	21.43	48.47	46.94	49.97
Inventory Days	--	1,995.83	201.55	263.81	183.56	189.51
Payable days	--	1,147.93	97.01	92.34	58.60	66.68
Cash Conversion Cycle	--	--	125.97	219.94	171.90	172.79

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.